Your browser doesn't support javascript.
loading
The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells.
Bilgin, Huseyin; Marku, Marisa; Yilmaz, Sultan Seval; Karahasan Yagci, Aysegul; Sili, Uluhan; Can, Baris; Can Sarinoglu, Rabia; Mulazimoglu Durmusoglu, Lutfiye; Haklar, Goncagul; Sirikci, Onder; Eksioglu Demiralp, Emel.
Afiliação
  • Bilgin H; Marmara University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey. Electronic address: huseyin.bilgin@marmara.edu.tr.
  • Marku M; Marmara University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
  • Yilmaz SS; Marmara University, School of Medicine, Department of Biochemistry, Istanbul, Turkey.
  • Karahasan Yagci A; Marmara University, School of Medicine, Department of Microbiology, Istanbul, Turkey.
  • Sili U; Marmara University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
  • Can B; Marmara University, School of Medicine, Department of Microbiology, Istanbul, Turkey.
  • Can Sarinoglu R; Marmara University, School of Medicine, Department of Microbiology, Istanbul, Turkey.
  • Mulazimoglu Durmusoglu L; Marmara University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
  • Haklar G; Marmara University, School of Medicine, Department of Biochemistry, Istanbul, Turkey. Electronic address: goncahaklar@marmara.edu.tr.
  • Sirikci O; Marmara University, School of Medicine, Department of Biochemistry, Istanbul, Turkey. Electronic address: ondersirikci@marmara.edu.tr.
  • Eksioglu Demiralp E; Istanbul Memorial Sisli Hospital, Tissue Typing and Immunology Laboratory, Istanbul, Turkey. Electronic address: emel.demiralp@memorial.com.tr.
Vaccine ; 40(18): 2619-2625, 2022 04 20.
Article em En | MEDLINE | ID: mdl-35339303

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article